Thrombosis treatment with fibrinolytics and prostacyclins

Details Thrombosis treatment with fibrinolytics and prostacyclins Thrombosis treatment with fibrinolytics and prostacyclins

1990-02-06

1994-05-31

Rollins, John W.

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

424 9464, 514530, 514822, 514824, A61K 3754, A61K 37547, A61K 31215

Patent

active

053167660

ABSTRACT:
The combination of a fibrinolytic and a prostacyclin analogue is very useful for thrombosis treatment, especially to avoid subsequent rethrombosis.

REFERENCES:
patent: 4496745 (1985-01-01), Amemiya et al.
patent: 4839169 (1989-06-01), Whittle
Chem. Abst., 103:98516r, 1985.
Schumacher et al., "Augmentation of Streptokinase-Induced Thrombolysis by Heparin and Prostacyclin", Journal of Cardiovascular Pharmacology, 7:739-746, 1985.
FASEB 68th Annual Meeting APS, ASPET, AAP, AIN, St. Louis, Mo., Apr. 1-6, 1984, Proceedings, Coronary Pharmacology Abstracts, p. 335, No. 297, Schumacher et al., "Streptokinase (SK) Thrombolysis in Dogs: Potentiation by Heparin (H) and Prostacyclin (PGl.sub.2)".
Blasko et al., Drugs Exptl. Clin. Res., IX, (7), 505-506 (1983).
Szczeklik et al., Thrombosis Research, 29, 655-660 (1983).

Affiliated with

Also associated with

Rating

Thrombosis treatment with fibrinolytics and prostacyclins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thrombosis treatment with fibrinolytics and prostacyclins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombosis treatment with fibrinolytics and prostacyclins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1626541